Citigroup’s OSR Health OSRH Stock Holding History

Citigroup’s Portfolio OSRH Stock Details OSRH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-384	Closed	-$232	–	6379
2026 Q1	$232	Buy	384 +26	+7%	+$14	﹤0.01%	5570
2025 Q4	$202	Buy	+358	New	+$221	﹤0.01%	5637

Other funds holding OSRH

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup's OSRH Position: Q2 2026 in Review

Citigroup sold out of OSR Health (OSRH) in Q2 2026, closing a stake of 384 shares — an estimated $232 sold.

Citigroup first reported a position in OSRH in Q4 2025 and held it in 2 quarters. The position peaked at $232 in Q1 2026. 13 funds tracked by Wall St. Rank hold OSRH as of Q2 2026.

Citigroup reported no remaining OSR Health position as of Q2 2026 after selling out during the quarter.
Citigroup sold 384 OSR Health shares in Q2 2026, an estimated $232.
Citigroup first reported a position in OSR Health in Q4 2025 and held it in 2 quarters.
Citigroup's OSR Health position peaked at $232 in Q1 2026.
13 funds tracked by Wall St. Rank held OSR Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.